IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis

IM Cannabis (Nasdaq: IMCC) announced that, effective August 27, 2026, its common shares began trading on Nasdaq on a 30:1 post-consolidated basis.

Rhea-AI Summary

IM Cannabis (Nasdaq: IMCC) announced that, effective August 27, 2026, its common shares began trading on Nasdaq on a 30:1 post-consolidated basis. The trading symbol remains IMCC, while the new CUSIP and ISIN are 44969Q505 and CA44969Q5059, respectively.

According to IM Cannabis, the share consolidation reduced outstanding common shares from 18,567,650 to 618,899, subject to rounding. No fractional shares were issued; fractions of at least one-half share were rounded up, and smaller fractions were cancelled. Exercise and conversion terms of outstanding convertible securities were proportionately adjusted. Computershare mailed instructions to registered holders for exchanging pre-consolidation certificates, while beneficial holders do not need to take action and should consult their intermediaries with any questions.

Positive

• 30:1 share consolidation completed and IMCC now trades on a post-consolidated basis on Nasdaq
• Outstanding common shares reduced from 18,567,650 to 618,899 following the consolidation

Negative

• Fractional holdings under one-half share were cancelled as part of the consolidation process, slightly reducing some shareholders’ positions

Argus Aug 28 session 15 alerts

-13.45% close to close 0.1x rel. volume Open Argus

Details

News Market Reaction – IMCC

-9.8% Trough in 6 hr 16 min

$2.28M Mkt Cap at Peak Alert

On Aug 28, the first trading day after this news, IMCC closed 13.45% below the previous close. Argus tracked a trough of -9.8% from its starting point during tracking. Our momentum scanner recorded 15 alerts for this stock that day.

Data tracked by StockTitan Argus for the Aug 28 session.

Key Figures

Share consolidation ratio: 30:1 Pre-consolidation shares: 18,567,650 Common Shares Post-consolidation shares: 618,899 Common Shares +2 more

Share consolidation ratio

30:1

Post-consolidation basis

Pre-consolidation shares

18,567,650 Common Shares

Before the Consolidation

Post-consolidation shares

618,899 Common Shares

After the Consolidation, subject to rounding

Trading commencement date

Aug. 27, 2026

Nasdaq post-consolidation trading

Fractional-share threshold

One-half Common Share

Fractions equal to or greater than one-half were rounded

Historical Context

5 past events · Latest: Aug 18

5 events

1. Aug 18

   Share consolidation

   24h Move

   -2.8%

   Announced 30:1 consolidation intended to support Nasdaq minimum bid-price compliance.

2. Aug 17

   Asset sale

   24h Move

   -12.5%

   Agreed to sell European-focused assets with assumed liabilities and retained Israeli operations.

3. Aug 13

   Earnings report

   24h Move

   -6.2%

   Reported lower revenue, wider operating loss, increased net loss, and liquidity concerns.

4. Aug 07

   Convertible financing

   24h Move

   +4.3%

   Raised convertible-note proceeds while issuing warrants and accepting share-based repayment terms.

5. Jul 27

   Leadership change

   24h Move

   +1.3%

   Director Alon Dayan resigned for personal reasons without reported operational disagreement.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

cusip, isin, consolidation, convertible securities

4 terms

cusip financial

"The Company's new CUSIP and ISIN numbers are 44969Q505 and CA44969Q5059"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

View in glossary

isin financial

"The Company's new CUSIP and ISIN numbers are 44969Q505 and CA44969Q5059"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

View in glossary

consolidation financial

"commenced trading today on the Nasdaq Capital Market LLC on a 30:1 post-consolidated basis"

Consolidation is a period when a stock’s price moves within a relatively narrow range, reflecting a balance between buyers and sellers after a prior rise or fall. It matters to investors because it often signals a pause before the next meaningful move — like a coiled spring — and helps with timing trades, setting risk limits and deciding whether momentum will resume upward or reverse downward.

View in glossary

convertible securities financial

"under any of the Company's outstanding convertible securities were proportionately adjusted"

Convertible securities are bonds or preferred shares that can be exchanged for a company’s common stock at a predetermined price or under specified conditions. They matter because they combine the steadiness of a loan or fixed dividend with the potential upside of ownership; like a safety‑net that carries a one‑time ticket to become a shareholder, they affect expected returns and can dilute existing stock if converted.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TORONTO and GLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the Company's common shares, no par value per share ("Common Shares"), commenced trading today on the Nasdaq Capital Market LLC ("Nasdaq") on a 30:1 post-consolidated basis (the "Consolidation").

The Company's existing trading symbol "IMCC" remains unchanged. The Company's new CUSIP and ISIN numbers are 44969Q505 and CA44969Q5059, respectively.

After giving effect to the Consolidation, the Common Shares were reduced from 18,567,650 to 618,899 Common Shares, subject to rounding for fractional Common Shares. No fractional Common Shares were issued in connection with the Consolidation. Instead, all fractional Common Shares equal to or greater than one-half resulting from the Consolidation were rounded to the next whole number, otherwise, fractional Common Shares representing less than one-half of a Common Share were cancelled. The exercise price and/or conversion price and number of Common Shares issuable under any of the Company's outstanding convertible securities were proportionately adjusted in connection with the Consolidation.

Computershare Investor Services Inc., the Company's registrar and transfer agent for the Common Shares, has mailed letters of transmittal to registered shareholders of record as of August 27, 2026 providing instructions for the exchange of share certificates or direct registration system statements representing pre-Consolidation Common Shares for share certificates or direct registration system statements representing post-Consolidation Common Shares. Registered shareholders may also obtain a copy of the letter of transmittal by accessing the Company's SEDAR+ profile at www.sedarplus.ca. Until surrendered, each Common Share certificate or direct registration system statement representing pre-consolidated Common Shares will represent the number of whole post-consolidated Common Shares to which the holder is entitled as a result of the Consolidation. No action is required by beneficial holders to receive post-consolidation Common Shares in connection with the Consolidation. Beneficial holders who hold their Common Shares through intermediaries (e.g., a broker, bank, trust company, investment dealer or other financial institution) and who have questions regarding how the Consolidation will be processed should contact their intermediaries with respect to the Consolidation.

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international company focused on building and scaling innovative businesses and technologies across global markets. The Company currently operates a medical cannabis platform serving patients in Israel and Germany while evaluating opportunities to expand into additional technology-driven sectors.

The IMC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws (collectively, "forward-looking statements"). Forward-looking statements are based on expectations, estimates, projections and interpretations as at the date of this press release and are often, but not always, identified by words and phrases such as "anticipate", "believe", "expect", "intend", "may", "plan", "should", "will", "would", "could", "estimate", "target", "subject to" and similar words or expressions.

Forward-looking statements in this press release include, without limitation, statements regarding the Consolidation, including the expected impact of the Consolidation on the per-share trading price of the Common Shares, the Company's intention and ability to regain and maintain compliance with Nasdaq's US$1.00 minimum bid price requirement and other continued listing requirements, and the timing and process for the exchange of certificates or direct registration system statements representing pre-Consolidation Common Shares.

Forward-looking statements are based on a number of assumptions, including, without limitation, that the Consolidation will result in a sustained increase in the per-share trading price of the Common Shares; that the trading price of the Common Shares will be sufficient for the Company to regain compliance with Nasdaq's US$1.00 minimum bid price requirement within the applicable compliance period; that Nasdaq will confirm compliance if the applicable requirements are met; that market conditions and trading activity will not materially impair the Company's ability to regain or maintain compliance with Nasdaq's continued listing requirements; that registered shareholders will be able to complete the exchange process in the ordinary course; and that there will be no material adverse change in the Company's business, operations, capital, financial condition, prospects or regulatory status.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, without limitation: the risk that the Consolidation may not result in a sustained increase in the per-share trading price of the Common Shares; the risk that the Company may not regain or maintain compliance with Nasdaq's US$1.00 minimum bid price requirement or other continued listing requirements, which could result in delisting; volatility and liquidity risks affecting the Common Shares; risks relating to the adjustment of convertible, exchangeable or exercisable securities; risks relating to communications with, and the exchange process for, registered and beneficial shareholders; regulatory, licensing and governmental policy risks in the jurisdictions where the Company operates; any unexpected failure to maintain in good standing or renew required licences; the ability of the Company and its subsidiaries (the "Group") to deliver on their sales commitments or growth objectives; reliance on third-party supply agreements and key personnel; the Group's ability to fulfill its obligations; the Group's possible exposure to liability and the anticipated outcome of litigation, disputes or legal proceedings involving the Group; the impact of increasing competition; adverse market conditions and supply chain constraints; debt default risk; risks arising from war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the multi-front war Israel is facing on the Company, its operations and the medical cannabis industry in Israel; risks related to the Company's focus on the markets in which it operates; the Company's ability to achieve sustainable profitability, increase shareholder value, manage costs, improve margins, grow or maintain sales, meet its goals and strategic plans, reduce costs or maintain revenues; and the other risks, uncertainties and factors set out under "Risk Factors" in the Company's annual report for the year ended December 31, 2025, available on SEDAR+ at www.sedarplus.ca  and EDGAR at www.sec.gov/edgar.

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management as of such date. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Michal Efraty

Investor & Public Relations
IM Cannabis Corp.
michal@efraty.com

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
info@imcannabis.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/im-cannabis-shares-commence-trading-on-301-consolidated-basis-302862048.html

SOURCE IM Cannabis Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happened to IM Cannabis (Nasdaq: IMCC) shares on August 27, 2026?

On August 27, 2026, IM Cannabis common shares began trading on a 30:1 post-consolidated basis. According to IM Cannabis, this consolidation reduced outstanding shares and adjusted all convertible securities proportionately while keeping the trading symbol IMCC unchanged on the Nasdaq Capital Market.

What is the 30:1 share consolidation for IMCC stock and how many shares are now outstanding?

The 30:1 consolidation means every 30 pre-consolidation shares became one new share. According to IM Cannabis, total common shares decreased from 18,567,650 to 618,899, subject to rounding rules applied to fractional shares resulting from the transaction.

How are fractional IM Cannabis (IMCC) shares treated in the 30:1 consolidation?

Fractional IM Cannabis shares are not issued under the consolidation. According to IM Cannabis, fractions of at least one-half share are rounded up to a whole share, while fractions under one-half share are cancelled and not compensated with additional common shares.

Do IM Cannabis (IMCC) shareholders need to do anything after the August 27, 2026 consolidation?

Registered shareholders must follow mailed instructions to exchange old certificates for post-consolidation ones. According to IM Cannabis, beneficial holders who own IMCC through brokers or banks do not need to act; intermediaries will process the consolidation in their accounts.

What are the new CUSIP and ISIN for IM Cannabis (IMCC) after the 30:1 consolidation?

After the consolidation, IM Cannabis common shares use CUSIP 44969Q505 and ISIN CA44969Q5059. According to IM Cannabis, only the identifiers changed; the Nasdaq trading symbol remains IMCC and the shares now reflect the adjusted consolidated share count.

How are IM Cannabis (IMCC) options and other convertible securities affected by the consolidation?

All outstanding IM Cannabis convertible securities are proportionately adjusted for the 30:1 consolidation. According to IM Cannabis, both the number of underlying common shares and each instrument’s exercise or conversion price were recalculated so holders maintain economically equivalent positions after the share consolidation.